These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8303660)
1. Impaired fibrinolysis in patients with Blackfoot disease. Wu HL; Yang WH; Wang MY; Shi GY Thromb Res; 1993 Nov; 72(3):211-8. PubMed ID: 8303660 [TBL] [Abstract][Full Text] [Related]
2. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026 [TBL] [Abstract][Full Text] [Related]
3. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580 [TBL] [Abstract][Full Text] [Related]
4. The effect of chronic allograft rejection on plasma regulators of fibrinolysis. Perkowska A; Elhasade A; Durlik M; Placha G; Gałazka Z; Lao M; Gaciong Z Ann Transplant; 2002; 7(1):44-51. PubMed ID: 12221903 [TBL] [Abstract][Full Text] [Related]
5. Hypofibrinolysis in patients with hypercoagulability: the roles of urokinase and of plasminogen activator inhibitor. Lau HK; Teitel JM; Cheung T; Kung SK; Garvey MB Am J Hematol; 1993 Dec; 44(4):260-5. PubMed ID: 8237997 [TBL] [Abstract][Full Text] [Related]
6. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease. Kaminski TW; Pawlak K; Karbowska M; Mysliwiec M; Grzegorzewski W; Kuna J; Pawlak D Int Urol Nephrol; 2018 Jan; 50(1):127-135. PubMed ID: 29058166 [TBL] [Abstract][Full Text] [Related]
7. Severity of venous insufficiency is related to the density of microvascular deposition of PAI-1, uPA and von Willebrand factor. Kolbach DN; Hamulyák K; Prins MH; Neumann HA; Cleutjens JP Vasa; 2004 Feb; 33(1):19-24. PubMed ID: 15061043 [TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Blann AD; Dobrotova M; Kubisz P; McCollum CN Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997 [TBL] [Abstract][Full Text] [Related]
9. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. van Kesteren PJ; Kooistra T; Lansink M; van Kamp GJ; Asscheman H; Gooren LJ; Emeis JJ; Vischer UM; Stehouwer CD Thromb Haemost; 1998 May; 79(5):1029-33. PubMed ID: 9609242 [TBL] [Abstract][Full Text] [Related]
13. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Comerota AJ; Chouhan V; Harada RN; Sun L; Hosking J; Veermansunemi R; Comerota AJ; Schlappy D; Rao AK Ann Surg; 1997 Sep; 226(3):306-13; discussion 313-4. PubMed ID: 9339937 [TBL] [Abstract][Full Text] [Related]
14. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium. Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic values of plasma levels of fibrinolytic markers in ovarian cancer. Ho CH; Yuan CC; Liu SM Gynecol Oncol; 1999 Dec; 75(3):397-400. PubMed ID: 10600296 [TBL] [Abstract][Full Text] [Related]
16. Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study. van den Berg VJ; Bouwens E; Umans VAWM; de Maat M; Manintveld OC; Caliskan K; Constantinescu AA; Mouthaan H; Cornel JH; Baart S; Akkerhuis KM; Boersma E; Kardys I Thromb Haemost; 2019 Dec; 119(12):1947-1955. PubMed ID: 31659734 [TBL] [Abstract][Full Text] [Related]
17. The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). Bandinelli F; Bartoli F; Perfetto E; Del Rosso A; Moggi-Pignone A; Guiducci S; Cinelli M; Fatini C; Generini S; Gabrielli A; Giacomelli R; Maddali Bongi S; Abbate R; Del Rosso M; Matucci Cerinic M Clin Exp Rheumatol; 2005; 23(5):671-7. PubMed ID: 16173244 [TBL] [Abstract][Full Text] [Related]
18. The effect of cyclosporine on regulators of fibrinolysis in plasma from renal allograft recipients. Elhasade AS; Perkowska A; Paczek L; Rowiński W; Soluch L; Szmidt J; Gałazka Z; Gaciong Z Ann Transplant; 1998; 3(1):13-8. PubMed ID: 9869892 [TBL] [Abstract][Full Text] [Related]
19. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients. Pawlak K; Pawlak D; Mysliwiec M Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326 [TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis. Wållberg-Jonsson S; Dahlén GH; Nilsson TK; Rånby M; Rantapää-Dahlqvist S Clin Rheumatol; 1993 Sep; 12(3):318-24. PubMed ID: 8258230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]